PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 30, 2026Journal of Pain and Symptom Management0 citationsOpen Access

Effect of specialist palliative care on acute healthcare in Stage IV cancer: prior event rate ratio

GYGrace M YANGXXiangmeiDHDavid HUI

Key Points

  • The research aims to evaluate the effect of specialist palliative care (SPC) on emergency department visits and hospitalizations in stage IV cancer patients using real-world data.
  • Retrospective observational cohort study comparing patients with stage IV cancer receiving SPC versus those not receiving SPC.
  • Utilization of the prior event rate ratio (PERR) method for bias correction.
  • Data collected from patients diagnosed at National Cancer Centre Singapore from January 2019 to December 2022.
  • Out of 7,144 patients, 1,499 (21.0%) received SPC, leading to a matched cohort of 5,948 patients.
  • Those receiving SPC showed a PERR hazard ratio of 0.644 (95% CI 0.524 to 0.792; P<0.001) for ED visits.
  • SPC initiation earlier than a year after diagnosis further improved reduction in ED visits and hospitalizations, with significant results even after delayed initiation.

Abstract

AbstractContext : The evidence for effect of specialist palliative care (SPC) on acute healthcare utilization is limited and inconclusive. Furthermore, randomized controlled trials may not reflect real-world clinical settings. Objectives : Effect of SPC on subsequent emergency department (ED) visits and inpatient hospitalizations among patients with stage IV cancer using real-world data and a novel prior event rate ratio (PERR) approach with bias-correction. Methods : Retrospective observational cohort study using the PERR method to compare ED visits and inpatient hospitalizations among patients with stage IV cancer who did versus did not receive SPC. We included patients diagnosed with stage IV cancer at National Cancer Centre Singapore between January 2019 and December 2022 and followed them up to July 2023. Each patient who received SPC was then matched with replacement to up to three patients who did not receive SPC during the study duration. Results Among 7,144 patients with stage IV cancer, 1,499 (21.0%) received SPC by July 2023. After 1:3 matching with replacement, there were 5,948 patients in the matched cohort. Compared to those who never received SPC, those who received SPC had a PERR hazard ratio estimate of 0.644 (95% CI 0.524 to 0.792; PConclusion : SPC was associated with lower rates of ED visits and hospitalizations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

YANG et al. (2026) studied this question.

synapsesocial.com/papers/69f2f0e31e5f7920c6386e7dhttps://doi.org/10.1016/j.jpainsymman.2026.04.612
Ask AI
Helpful
Bookmark
Share
View Full Paper